UmeshJadhavChaudhariMD

Physician

Dr. Chaudhari is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 1996 - 1999
Rutgers Robert Wood Johnson Medical SchoolClass of 1996

PubMed

143 citations
Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab: Pooled Data From Randomized Trials
Jennifer G. Robinson, Robert S. Rosenson, Michel Farnier, Umesh Chaudhari, William J. Sasiela
Journal of the American College of Cardiology. 2017-02-07
46 citations
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholeste...
John J.P. Kastelein, G. Kees Hovingh, Gisle Langslet, Marie T. Baccara-Dinet, Daniel A. Gipe
Journal of Clinical Lipidology. 2017-01-01
278 citations
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin the...
Dean J. Kereiakes, Jennifer G. Robinson, Christopher P. Cannon, Christelle Lorenzato, Robert Pordy
American Heart Journal. 2015-06-01

Abstracts/Posters

Pozelimab, a Human Antibody Against Complement Factor C5, Demonstrates Robust Inhibition of Alternative Complement Activity Both in Normal Human Serum and in Phase I N...
Umesh Chaudhari, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Epidemiology of PNH and Real-World Treatment Patterns Following an Incident PNH Diagnosis in the US
Umesh Chaudhari, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019